# FDA Inspection 1313094 - Nashat Y Gabrail MD - April 15, 2026

Source: https://www.keypedia.com/records/fda_inspections/nashat-y-gabrail-md/9584043f-f4c9-49a6-84ee-d98cad57a314
Source feed: FDA_Inspections

> FDA Inspection 1313094 for Nashat Y Gabrail MD on April 15, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1313094
- Company Name: Nashat Y Gabrail MD
- Inspection Date: 2026-04-15
- Product Type: Human Drugs
- Office Name: Cincinnati District Office

## Related Documents

- [FDA Inspection 1116861 - 2020-01-23](https://www.keypedia.com/records/fda_inspections/nashat-y-gabrail-md/a9cf3ef1-bb98-4125-9258-ea5fe9255e97)
- [FDA Inspection 911090 - 2015-01-21](https://www.keypedia.com/records/fda_inspections/nashat-y-gabrail-md/9d9e4bc8-afe6-4300-b114-0ba9365acf62)
- [FDA Inspection 634783 - 2009-12-17](https://www.keypedia.com/records/fda_inspections/nashat-y-gabrail-md/2bce4786-8147-4ea0-8277-7d1c254bd695)

Company: https://www.keypedia.com/companies/nashat-y-gabrail-md/b9479e97-f159-4b20-9f2d-4065f6f89143

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22